CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

CIViC Evidence Items

660 evidence items indexed

Evidence Level Distribution

CIViC evidence levels reflect study design quality, from A (strongest) to E (weakest).

AValidated — meta-analysis, systematic review, or major guideline
BClinical — prospective trial or retrospective cohort study
CCase study — single case report or small case series
DPreclinical — in vitro or animal model data
EInferential — computational prediction or biological rationale

Gene × Evidence Type

Count of CIViC evidence items per gene and evidence type category. Hover a column header for the type definition.

PredictiveDiagnosticPrognosticFunctionalPredispos.Oncogenic
BCR::ABL132311
BRAF18642621
EGFR2481232
EML4::ALK64
ERBB21422
FLT355221
KIT10237
KRAS1594244
PIK3CA156164
PTEN5313121
TP5352401002
VHL52363515
Predictive:Links a variant to treatment response or resistance
Diagnostic:Supports or refutes a specific disease diagnosis
Prognostic:Informs disease progression or clinical outcome
Functional:Characterises the biological effect of a variant
Predisposing:Germline variant associated with cancer predisposition
Oncogenic:Characterises the variant's role in oncogenesis
Clear
LevelGeneVariantTypeDirectionSignificanceDiseaseDrugsSource
CVHLR161* (c.481C>T)PredisposingSupportsPredispositionVon Hippel-Lindau DiseaseRuiz-Llorente et al., 2004
CVHLL184P (c.551T>C)PredisposingSupportsPredispositionVon Hippel-Lindau DiseaseRuiz-Llorente et al., 2004
CVHLF76del (c.227_229del)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseHes et al., 2007
CVHLW88fs (c.261dup)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseHes et al., 2007
CVHLR161* (c.481C>T)PredisposingN/AVon Hippel-Lindau DiseaseMathó et al., 2016
CVHLR167Q (c.500G>A)PredisposingN/AVon Hippel-Lindau DiseaseTaylor et al., 2018
CVHL3p26.3-25.3 11Mb delPredisposingN/AVon Hippel-Lindau DiseaseSuzuki-Muromoto et al., 2016
CVHLExon 3 DeletionPredisposingSupportsPredispositionVon Hippel-Lindau DiseaseValero et al., 2016
CVHLS65W (c.194C>G)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseLaunbjerg et al., 2017
CVHLA122I (c.364_365GC>AT)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseNeumann et al., 2002
CVHLS65W (c.194C>G)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseZhang et al., 2015
CVHLc.−213− ?_463 ?delPredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLP81S (c.241C>T)PredisposingN/AVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLV87fs (c.259_260insA)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLG93S (c.277G>A)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLSplice Site (c.340+1G>A)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLc.341-59_341-14delPredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLR120G (c.358A>G)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLF136S (c.407T>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLP154= (c.462A>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLSplice Site (c.463+2T>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLY156C (c.467A>G)PredisposingN/AVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLV166A (c.497T>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLR167W (c.499C>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLR167Q (c.500G>A)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLV170D (c.509T>A)PredisposingN/AVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLE189fs (c.565del)PredisposingN/AVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLRearrangementPredisposingN/AVon Hippel-Lindau DiseaseKruizinga et al., 2014
CVHLS111C (c.331A>T)PredisposingN/AVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLS111N (c.332G>A)PredisposingN/AVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLR113* (c.337C>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLG114Vfs*45 (c.339delA)PredisposingN/AVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLH115Q (c.345C>G)PredisposingN/AVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLR120G (c.358A>G)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLN131T (c.392A>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLT133fs (c.397del)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLL135* (c.404T>A)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLP154L (c.461C>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLSplice Site (c.463+2T>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLT157I (c.470C>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLL158P (c.473T>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLR161* (c.481C>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLC162Y (c.485G>A)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLC162W (c.486C>G)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLQ164L (c.491A>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLR167W (c.499C>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLR167Q (c.500G>A)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLR167P (c.500G>C)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLL178P (c.532C>T)PredisposingN/AVon Hippel-Lindau DiseaseBausch et al., 2016
CVHLQ195* (c.583C>T)PredisposingSupportsUncertain SignificanceVon Hippel-Lindau DiseaseBausch et al., 2016
Page 7 of 14